---
document_datetime: 2025-02-14 11:10:38
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/veoza-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: veoza-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 1.523062
conversion_datetime: 2025-12-21 23:42:20.02436
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Veoza

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                             | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                  |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/231/2 02405    | Periodic Safety Update EU Single assessment - fezolinetant                                                                                                        | 12/12/2024                          | 07/02/2025                                  | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/231/202405. |
| IB/0006              | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time | 29/10/2024                          | n/a                                         |                                  |                                                                                                                                          |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | data                                                                                                                                                                                                |            |            |                        |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| IB/0004   | B.II.f.1.z - Stability of FP - Change in the shelf-life or storage conditions of the finished product - Other variation                                                                             | 09/08/2024 | n/a        |                        |
| IAIN/0003 | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release                                                                          | 15/04/2024 | 07/02/2025 | Annex II and PL        |
| IB/0002   | B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation                                                                                | 07/03/2024 | n/a        |                        |
| IB/0001   | B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes | 16/02/2024 | 07/02/2025 | SmPC, Labelling and PL |